BAL PHARMA
|
The Current P/E Ratio of BAL PHARMA is 18.31.
Share Price | ₹82.8 | Sep 26,2025 |
Market Cap | ₹131.6 Cr | |
Earnings-TTM | ₹7.2 Cr | TTM-Consolidated Results |
Price/Earnings | 18.31x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of BAL PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹131.6 Cr] as on Sep 26,2025
(/) Earnings [ ₹7.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 18.31x ]
Thus, for BAL PHARMA , the investors are currently willing to pay 18.31 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BAL PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BAL PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of BAL PHARMA
PE Ratio Performance Analysis for BAL PHARMA
- BAL PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 24.80x.
- BAL PHARMA 's operated at median p/e ratio of 19.51x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAL PHARMA 's p/e ratio peaked in Mar2023 at 40.83x.
- BAL PHARMA 's p/e ratio hit its five-year low in Mar2021 of 16.8x.
How does BAL PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
BAL PHARMA | 7.19 | 18.31 | 131.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 36.56 | 380,666.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 65.51 | 151,060.0 |
CIPLA LTD | 5,406.81 | 22.39 | 121,080.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.24 | 120,605.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.26 | 104,556.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.75 | 102,422.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.18 | 98,213.5 |
LUPIN LTD | 3,722.18 | 23.57 | 87,731.8 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.53 | 63,342.2 |
ABBOTT INDIA LTD | 1,452.29 | 43.54 | 63,228.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BAL PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.26x |
Max industry PE | 65.51x |
Median industry PE | 23.57x |
Average industry PE | 34.71x |
You may also like the below Video Courses